Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Nature Communications

Topics

Biology

Biochemistry

Chemistry

Medicine

Pathology

Show all topics

DOI

10.1038/s41467-020-18233-x

License

CC-BY

Other Formats

PDF